We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current FGEN market cap is 100.75M. The company's latest EPS is USD -2.8777 and P/E is -0.36.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 15.73M | 34.37M | 36.16M | 44.32M | 40.13M |
| Operating Income | -93.25M | -65.87M | -76.09M | -88.05M | -63.48M |
| Net Income | -91.65M | -66.18M | -76.71M | -87.68M | -63.62M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 256.58M | 176.32M | 235.31M | 140.73M | 147.75M |
| Operating Income | -89.31M | -192.08M | -287.52M | -299.45M | -281.82M |
| Net Income | -76.97M | -189.29M | -290.02M | -293.65M | -284.23M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 608.84M | 610.09M | 538.54M | 515.13M | 460.43M |
| Total Liabilities | 562.56M | 611.57M | 567.43M | 575.43M | 575.63M |
| Total Equity | 46.27M | -1.48M | -28.89M | -81.79M | -136.68M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 857.4M | 826.84M | 773.82M | 610.09M | 423.53M |
| Total Liabilities | 321.99M | 385.39M | 544.71M | 611.57M | 585.73M |
| Total Equity | 535.41M | 441.45M | 229.11M | -1.48M | -183.68M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -93.42M | -145.93M | -101.59M | -212.16M | -296.7M |
| Investing | 88.02M | 89.12M | 103.48M | 89.2M | 143.42M |
| Financing | -1.9M | 46.78M | 31.49M | 123.02M | 123M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -78.71M | 81.6M | -82.23M | -145.93M | -315.02M |
| Investing | 120.02M | 452.49M | -426.97M | 89.12M | 153.66M |
| Financing | -4.3M | 13.34M | -563k | 46.78M | 122.75M |
| Market Cap | 100.75M |
| Price to Earnings Ratio | -0.36 |
| Price to Sales Ratio | 0.7 |
| Price to Cash Ratio | 0.9 |
| Price to Book Ratio | -0.63 |
| Dividend Yield | - |
| Shares Outstanding | 98.77M |
| Average Volume (1 week) | 1.38M |
| Average Volume (1 Month) | 1.87M |
| 52 Week Change | -93.75% |
| 52 Week High | 19.47 |
| 52 Week Low | 0.3333 |
| Spread (Intraday) | 0.07 (6.54%) |
| Company Name | FibroGen Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.fibrogen.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
